PinkDx raised $5M in additional Series A funding led by Catalio Capital Management to advance its first test for diagnosing potential gynecologic cancer.

Jan 24, 2025•11 months ago

Amount Raised

$5 Million

Round Type

series a

Daly CityBiotechnology

Investors

BevcSandbox Clinical VenturesBlue Venture FundMayo ClinicByers CapitalMountain Group PartnersThe Production BoardCatalio Capital Management

Description

PinkDx, based in Daly City, CA, has secured an additional $5M in Series A funding to enhance its diagnostic test for women potentially facing gynecologic cancer. This round was led by Catalio Capital Management, with participation from several new investors and existing backers.

Company Information

Company

PinkDx

Location

2001 Junipero Serra Blvd., Suite 610

Daly City, California, United States

About

PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive impact on their lives. The company's first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer.

Related People

4 contacts

Funding Insights

Based on industry data

VC-backed spending patterns